which later won FDA approval for weightloss in 2023 under the brand name Zepbound. A similar version of this drug, called Mounjaro, has been available to people with type 2 diabetes since ...
Around the world, obesity rates have been stubbornly climbing for decades, if anything accelerating in recent years. But now newly released data finds that the US adult obesity rate fell by around two ...